|Bid||18.50 x 800|
|Ask||22.98 x 1000|
|Day's Range||17.67 - 19.58|
|52 Week Range||2.52 - 38.50|
|Beta (5Y Monthly)||4.00|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||37.50|
Seres Therapeutics, Inc., (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will participate in two upcoming investor conferences:
Seres Therapeutics, Inc., (Nasdaq: MCRB), a leading microbiome platform company developing a novel class of multifunctional bacterial therapeutics designed to functionally interact with host cells and tissues to treat disease, today announced that management will host a conference call and live audio webcast on March 2, 2021 at 8:30 a.m. ET to discuss fourth quarter and full year 2020 results and provide a general business update.
While Seres Therapeutics, Inc. ( NASDAQ:MCRB ) shareholders are probably generally happy, the stock hasn't had...